Paramagnetic nanoparticles as a platform for FRET-based sarcosine picomolar detection
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25746688
PubMed Central
PMC4352859
DOI
10.1038/srep08868
PII: srep08868
Knihovny.cz E-zdroje
- MeSH
- dextrany chemie ultrastruktura MeSH
- lidé MeSH
- magnetické nanočástice chemie ultrastruktura MeSH
- molekulární zobrazování metody MeSH
- monoklonální protilátky chemie imunologie MeSH
- nádorové biomarkery analýza MeSH
- nádorové buněčné linie MeSH
- nádory prostaty chemie diagnóza imunologie MeSH
- nanokapsle chemie ultrastruktura MeSH
- reprodukovatelnost výsledků MeSH
- rezonanční přenos fluorescenční energie metody MeSH
- sarkosin analýza imunologie MeSH
- senzitivita a specificita MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- dextrany MeSH
- ferumoxtran-10 MeSH Prohlížeč
- magnetické nanočástice MeSH
- monoklonální protilátky MeSH
- nádorové biomarkery MeSH
- nanokapsle MeSH
- sarkosin MeSH
Herein, we describe an ultrasensitive specific biosensing system for detection of sarcosine as a potential biomarker of prostate carcinoma based on Förster resonance energy transfer (FRET). The FRET biosensor employs anti-sarcosine antibodies immobilized on paramagnetic nanoparticles surface for specific antigen binding. Successful binding of sarcosine leads to assembly of a sandwich construct composed of anti-sarcosine antibodies keeping the Förster distance (Ro) of FRET pair in required proximity. The detection is based on spectral overlap between gold-functionalized green fluorescent protein and antibodies@quantum dots bioconjugate (λex 400 nm). The saturation curve of sarcosine based on FRET efficiency (F₆₀₄/F₅₁₀ ratio) was tested within linear dynamic range from 5 to 50 nM with detection limit down to 50 pM. Assembled biosensor was then successfully employed for sarcosine quantification in prostatic cell lines (PC3, 22Rv1, PNT1A), and urinary samples of prostate adenocarcinoma patients.
Zobrazit více v PubMed
Siegel R., Naishadham D. & Jemal A. Cancer statistics, 2013. CA-Cancer J Clin 63, 11–30 (2013). PubMed
Heger Z. PubMed
Jiang Y. Q., Cheng X. L., Wang C. A. & Ma Y. F. Quantitative Determination of Sarcosine and Related Compounds in Urinary Samples by Liquid Chromatography with Tandem Mass Spectrometry. Anal Chem 82, 9022–9027 (2010). PubMed
Riedel M. PubMed
Burton C., Gamagedara S. & Ma Y. F. A novel enzymatic technique for determination of sarcosine in urine samples. Anal Methods 4, 141–146 (2012).
Lan J. M. PubMed
Chen J., Zhang J., Zhang W. P. & Chen Z. L. Sensitive determination of the potential biomarker sarcosine for prostate cancer by LC-MS with N,N '-dicyclohexylcarbodiimide derivatization. J Sep Sci 37, 14–19 (2014). PubMed
Haviv A. H., Greneche J. M. & Lellouche J. P. Aggregation Control of Hydrophilic Maghemite (gamma-Fe2O3) Nanoparticles by Surface Doping Using Cerium Atoms. J Am Chem Soc 132, 12519–12521 (2010). PubMed
Guo Q. J., Teng X. W., Rahman S. & Yang H. Patterned Langmuir-Blodgett films of mondisperse nanoparticles of iron oxide using soft lithography. J Am Chem Soc 125, 630–631 (2003). PubMed
El-Boubbou K., Gruden C. & Huang X. Magnetic glyco-nanoparticles: A unique tool for rapid pathogen detection, decontamination, and strain differentiation. J Am Chem Soc 129, 13392–13393 (2007). PubMed
Schwegmann H., Feitz A. J. & Frimmel F. H. Influence of the zeta potential on the sorption and toxicity of iron oxide nanoparticles on S. cerevisiae and E. coli. J Colloid Interface Sci 347, 43–48 (2010). PubMed
Hodek P.
Shaner N. C., Steinbach P. A. & Tsien R. Y. A guide to choosing fluorescent proteins. Nat Methods 2, 905–909 (2005). PubMed
Bale S. S. PubMed
Love J. C. PubMed
Qu L. H. & Peng X. G. Control of photoluminescence properties of CdSe nanocrystals in growth. J Am Chem Soc 124, 2049–2055 (2002). PubMed
Janu L. PubMed
Casanova D. PubMed
Ryan D., Robards K., Prenzler P. D. & Kendall M. Recent and potential developments in the analysis of urine: A review. Anal Chim Acta 684, 17–29 (2011). PubMed
Abate-Shen C. & Shen M. M. Diagnostics The prostate-cancer metabolome. Nature 457, 799–800 (2009). PubMed
Zitka O. PubMed
A Rapid Method for the Detection of Sarcosine Using SPIONs/Au/CS/SOX/NPs for Prostate Cancer Sensing
DNA-magnetic Particle Binding Analysis by Dynamic and Electrophoretic Light Scattering
Using CdTe/ZnSe core/shell quantum dots to detect DNA and damage to DNA